MedPath

Evaluation of Enamel Demineralization During Clear Aligner Orthodontic Treatment

Not Applicable
Completed
Conditions
White Spot Lesion
Registration Number
NCT04107012
Lead Sponsor
Jordan University of Science and Technology
Brief Summary

Development of white spot lesions (enamel demineralization) will be evaluated quantitatively during clear aligner orthodontic treatment compared to conventional fixed appliances using quantitative light induced fluorescence (QLF)

Detailed Description

White spot lesion (WSL) may develop around fixed orthodontic appliances. With clear aligners, however, the issue is not controversial. WSL will be monitored in 2 groups of patients; one group using clear aligners and one group wearing fixed orthodontic appliances for 3 months. QLF images will be taken before treatment (T0) and 3 months after commencement of the treatment (T1). The results will be compared between the two groups

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
49
Inclusion Criteria
  • Healthy patients from both genders aged (17 - 24 years).
  • Class I malocclusion with mild to moderate crowding (≤ 5 mm).
  • Non-extraction treatment plan.
  • Optimum oral Hygiene before treatment with no signs of gingivitis and/or periodontitis.
  • Maximum of 3 restored teeth.
  • Absence of defective enamel formation in the form of hypocalcification or hypoplasia.
Exclusion Criteria

-Patients with poor oral hygiene, defective enamel, extensive restorations and salivary glands diseases were excluded.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Delta F3 months

Incideance of Fluorescence loss

Lesion area3 months

Incidence of the white spot lesion area

Secondary Outcome Measures
NameTimeMethod
Number of new lesions3 months

The number of newly developed white spot lesion during orthodontic treatment

ΔR303 months

Rate of plaque on tooth surfaces

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.